ArticleFrontiers in oncology2025
Case Report: Synchronous cervical, gastric and rectal metastases in occult breast cancer.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exosome-mediated organotropism in breast cancer metastasis: bridging the gap between molecular mechanisms and clinical application.Clinical & experimental metastasis · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Occult breast cancer (OBC) is characterized as a breast carcinoma that remains undetectable through imaging modalities. OBC is a rare condition, accounting for only 0.3%-1.0% of all breast cancers, and is often clinically associated with metastases to the axillary and cervical lymph nodes. Metastasis of occult primary breast cancer to the cervix, stomach, or rectum is exceptionally rare. Here, we report the case of a 64-year-old woman presenting with clinical symptoms of urinary urgency, frequency, severe rectal discomfort, and altered stool morphology. Ga68-positron emission tomography-computed tomography (Ga68-FAPI PET/CT) identified diffuse tumor-associated fibrin expression within the gastric wall, while 18F-fluorodeoxyglucose PET/CT (18F-FDG PET/CT) revealed marked annular thickening of the rectal wall. Notably, imaging evaluations, including mammography, breast ultrasonography, and 18F-FDG PET/CT, failed to detect primary breast lesions. Histopathological examination and immunohistochemical analysis of biopsied cervical, gastric, and rectal lesions confirmed the diagnosis of OBC. Following six months of treatment with letrozole (1mg/day) in combination with dalpiciclib the patient demonstrated significant symptomatic relief, with remarkable reduction in the lesions located in the cervix, stomach, and rectum. This case represents the first documented instance of occult primary breast cancer with simultaneous metastases to the cervix, stomach, and rectum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.